Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Biotech Homepage
Biotech
Cullinan CEO sets tone for bispecific's upcoming lupus readout
While CAR-T's 100% remission rate has set the benchmark in lupus, Cullinan's CEO argues the bar is “very different” for an off-the-shelf regimen.
Angus Liu
Feb 7, 2025 5:00am
J&J vet jumps to Affinia—Chutes & Ladders
Feb 7, 2025 8:30am
BMS backs out of Dupixent fight, axing asset despite phase 3 win
Feb 7, 2025 6:26am
Lilly's next focus: Testing incretins in neuro, immunology fields
Feb 6, 2025 2:35pm
Acelyrin to be absorbed into Alumis in all-stock merger
Feb 7, 2025 5:35am
Tenpoint preps FDA filing after scoring in presbyopia study
Jan 9, 2025 3:39pm
Medtech News
Analysts tip thyroid disorder awareness push to boost outcomes
Jan 31, 2025 10:57am
BD survey shows fear and discomfort delay gynecology visits
Jan 10, 2025 8:59am
Lil Jon delivers scat rap to promote Exact Sciences' cancer kit
Dec 3, 2024 9:25am
Skills shortage holding back pharma's digital transformation
Nov 18, 2024 3:05pm
See More Medtech News